Prevalence and outcomes of Covid-19 in Parkinson's disease: Acute settings and hospital.
Int Rev Neurobiol
; 165: 35-62, 2022.
Article
en En
| MEDLINE
| ID: mdl-36208906
ABSTRACT
The global explosion of COVID-19 necessitated the rapid dissemination of information regarding SARS-CoV-2. Hence, COVID-19 prevalence and outcome data in Parkinson's disease patients were disseminated at a time when we only had part of the picture. In this chapter we firstly discuss the current literature on the prevalence of COVID-19 in people with PD. We then discuss outcomes from COVID-19 in people with PD, specifically risk of hospitalization and mortality. Finally, we discuss specific contributing and confounding factors which may put PD patients at higher or lower risk from COVID-19.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Enfermedad de Parkinson
/
COVID-19
Tipo de estudio:
Prevalence_studies
/
Risk_factors_studies
Límite:
Humans
Idioma:
En
Revista:
Int Rev Neurobiol
Año:
2022
Tipo del documento:
Article
País de afiliación:
Canadá